Xencor Reports First Quarter 2021 Financial Results

Go back to Xencor Reports First Quarter 2021 Financial Results

Xencor (XNCR) Tops Q1 EPS by 63c, Revenues Beat

May 5, 2021 4:40 PM EDT

Xencor (NASDAQ: XNCR) reported Q1 EPS of ($0.04), $0.63 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $33.97 million versus the consensus estimate of $16.45 million.

"We continue to expand and mature our clinical portfolio of XmAb® drug candidates, recently initiating a... More